Inflammation-Related Carcinogenesis and Prevention in Esophageal Adenocarcinoma Using Rat Duodenoesophageal Reflux Models
Development from chronic inflammation to Barrett’s adenocarcinoma is known as one of the inflammation-related carcinogenesis routes. Gastroesophageal reflux disease induces regurgitant esophagitis, and esophageal mucosa is usually regenerated by squamous epithelium, but sometimes and somewhere repla...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2011-08-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | http://www.mdpi.com/2072-6694/3/3/3206/ |
| _version_ | 1797720946395578368 |
|---|---|
| author | Koichi Miwa Tetsuo Ohta Takanori Hattori Koji Nishijima Tomoharu Miyashita Shozo Sasaki Katsunobu Oyama Takashi Fujimura |
| author_facet | Koichi Miwa Tetsuo Ohta Takanori Hattori Koji Nishijima Tomoharu Miyashita Shozo Sasaki Katsunobu Oyama Takashi Fujimura |
| author_sort | Koichi Miwa |
| collection | DOAJ |
| description | Development from chronic inflammation to Barrett’s adenocarcinoma is known as one of the inflammation-related carcinogenesis routes. Gastroesophageal reflux disease induces regurgitant esophagitis, and esophageal mucosa is usually regenerated by squamous epithelium, but sometimes and somewhere replaced with metaplastic columnar epithelium. Specialized columnar epithelium, so-called Barrett’s epithelium (BE), is a risk factor for dysplasia and adenocarcinoma in esophagus. Several experiments using rodent model inducing duodenogastroesophageal reflux or duodenoesophageal reflux revealed that columnar epithelium, first emerging at the proliferative zone, progresses to dysplasia and finally adenocarcinoma, and exogenous carcinogen is not necessary for cancer development. It is demonstrated that duodenal juice rather than gastric juice is essential to develop esophageal adenocarcinoma in not only rodent experiments, but also clinical studies. Antireflux surgery and chemoprevention by proton pump inhibitors, nonsteroidal anti-inflammatory drugs, selective cyclooxygenase-2 inhibitors, green tea, retinoic acid and thioproline showed preventive effects on the development of Barrett’s adenocarcinoma in rodent models, but it remains controversial whether antireflux surgery could regress BE and prevent esophageal cancer in clinical observation. The Chemoprevention for Barrett's Esophagus Trial (CBET), a phase IIb, multicenter, randomized, double-masked study using celecoxib in patients with Barrett's dysplasia failed to prove to prevent progression of dysplasia to cancer. The AspECT (Aspirin Esomeprazole Chemoprevention Trial), a large multicenter phase III randomized trial to evaluate the effects of esomeprazole and/or aspirin on the rate of progression to high-grade dysplasia or adenocarcinoma in patients with BE is now ongoing. |
| first_indexed | 2024-03-12T09:26:50Z |
| format | Article |
| id | doaj.art-e77da64e822e4bfea84b3641da5309be |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-12T09:26:50Z |
| publishDate | 2011-08-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-e77da64e822e4bfea84b3641da5309be2023-09-02T14:10:26ZengMDPI AGCancers2072-66942011-08-01333206322410.3390/cancers3033206Inflammation-Related Carcinogenesis and Prevention in Esophageal Adenocarcinoma Using Rat Duodenoesophageal Reflux ModelsKoichi MiwaTetsuo OhtaTakanori HattoriKoji NishijimaTomoharu MiyashitaShozo SasakiKatsunobu OyamaTakashi FujimuraDevelopment from chronic inflammation to Barrett’s adenocarcinoma is known as one of the inflammation-related carcinogenesis routes. Gastroesophageal reflux disease induces regurgitant esophagitis, and esophageal mucosa is usually regenerated by squamous epithelium, but sometimes and somewhere replaced with metaplastic columnar epithelium. Specialized columnar epithelium, so-called Barrett’s epithelium (BE), is a risk factor for dysplasia and adenocarcinoma in esophagus. Several experiments using rodent model inducing duodenogastroesophageal reflux or duodenoesophageal reflux revealed that columnar epithelium, first emerging at the proliferative zone, progresses to dysplasia and finally adenocarcinoma, and exogenous carcinogen is not necessary for cancer development. It is demonstrated that duodenal juice rather than gastric juice is essential to develop esophageal adenocarcinoma in not only rodent experiments, but also clinical studies. Antireflux surgery and chemoprevention by proton pump inhibitors, nonsteroidal anti-inflammatory drugs, selective cyclooxygenase-2 inhibitors, green tea, retinoic acid and thioproline showed preventive effects on the development of Barrett’s adenocarcinoma in rodent models, but it remains controversial whether antireflux surgery could regress BE and prevent esophageal cancer in clinical observation. The Chemoprevention for Barrett's Esophagus Trial (CBET), a phase IIb, multicenter, randomized, double-masked study using celecoxib in patients with Barrett's dysplasia failed to prove to prevent progression of dysplasia to cancer. The AspECT (Aspirin Esomeprazole Chemoprevention Trial), a large multicenter phase III randomized trial to evaluate the effects of esomeprazole and/or aspirin on the rate of progression to high-grade dysplasia or adenocarcinoma in patients with BE is now ongoing.http://www.mdpi.com/2072-6694/3/3/3206/inflammation-metaplasia-adenocarcinoma sequenceBarrett’s esophagusduodenogastroesophageal refluxchemoprevention for esophageal adenocarcinomaantireflux surgeryproton pump inhibitorsnonsteroidal anti-inflammatory drugsselective cyclooxygenase-2 inhibitorsthioproline |
| spellingShingle | Koichi Miwa Tetsuo Ohta Takanori Hattori Koji Nishijima Tomoharu Miyashita Shozo Sasaki Katsunobu Oyama Takashi Fujimura Inflammation-Related Carcinogenesis and Prevention in Esophageal Adenocarcinoma Using Rat Duodenoesophageal Reflux Models Cancers inflammation-metaplasia-adenocarcinoma sequence Barrett’s esophagus duodenogastroesophageal reflux chemoprevention for esophageal adenocarcinoma antireflux surgery proton pump inhibitors nonsteroidal anti-inflammatory drugs selective cyclooxygenase-2 inhibitors thioproline |
| title | Inflammation-Related Carcinogenesis and Prevention in Esophageal Adenocarcinoma Using Rat Duodenoesophageal Reflux Models |
| title_full | Inflammation-Related Carcinogenesis and Prevention in Esophageal Adenocarcinoma Using Rat Duodenoesophageal Reflux Models |
| title_fullStr | Inflammation-Related Carcinogenesis and Prevention in Esophageal Adenocarcinoma Using Rat Duodenoesophageal Reflux Models |
| title_full_unstemmed | Inflammation-Related Carcinogenesis and Prevention in Esophageal Adenocarcinoma Using Rat Duodenoesophageal Reflux Models |
| title_short | Inflammation-Related Carcinogenesis and Prevention in Esophageal Adenocarcinoma Using Rat Duodenoesophageal Reflux Models |
| title_sort | inflammation related carcinogenesis and prevention in esophageal adenocarcinoma using rat duodenoesophageal reflux models |
| topic | inflammation-metaplasia-adenocarcinoma sequence Barrett’s esophagus duodenogastroesophageal reflux chemoprevention for esophageal adenocarcinoma antireflux surgery proton pump inhibitors nonsteroidal anti-inflammatory drugs selective cyclooxygenase-2 inhibitors thioproline |
| url | http://www.mdpi.com/2072-6694/3/3/3206/ |
| work_keys_str_mv | AT koichimiwa inflammationrelatedcarcinogenesisandpreventioninesophagealadenocarcinomausingratduodenoesophagealrefluxmodels AT tetsuoohta inflammationrelatedcarcinogenesisandpreventioninesophagealadenocarcinomausingratduodenoesophagealrefluxmodels AT takanorihattori inflammationrelatedcarcinogenesisandpreventioninesophagealadenocarcinomausingratduodenoesophagealrefluxmodels AT kojinishijima inflammationrelatedcarcinogenesisandpreventioninesophagealadenocarcinomausingratduodenoesophagealrefluxmodels AT tomoharumiyashita inflammationrelatedcarcinogenesisandpreventioninesophagealadenocarcinomausingratduodenoesophagealrefluxmodels AT shozosasaki inflammationrelatedcarcinogenesisandpreventioninesophagealadenocarcinomausingratduodenoesophagealrefluxmodels AT katsunobuoyama inflammationrelatedcarcinogenesisandpreventioninesophagealadenocarcinomausingratduodenoesophagealrefluxmodels AT takashifujimura inflammationrelatedcarcinogenesisandpreventioninesophagealadenocarcinomausingratduodenoesophagealrefluxmodels |